Risk Stratification in Acute Care: The Meaning of suPAR Measurement in Triage

NACompletedINTERVENTIONAL
Enrollment

20,000

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

April 6, 2017

Study Completion Date

April 6, 2017

Conditions
TriageRisk Stratification With Biomarker
Interventions
BEHAVIORAL

suPAR measurement

The biomarker suPAR will be measured on all patients included in the study. Before the study period the doctors will receive information on suPAR. We want to study if the information provided by suPAR is useful in emergency medicine. Interventions depends on the clinical issue, as suPAR is an unspecific marker of disease. Usually a elevated suPAR level could result in more investigation e.g. diagnostic procedures or follow up, while a low suPAR could result in faster discharge.

Trial Locations (1)

2730

Herlev Hospital, Department of Cardiology, Herlev

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT02643459 - Risk Stratification in Acute Care: The Meaning of suPAR Measurement in Triage | Biotech Hunter | Biotech Hunter